Well, the makers of Dysport, a competitor to Botox, have created their own version of this popular commercial. It’s called the Dysport Challenge. Now, our office doesn’t use Dysport, we love our Botox, so we aren’t in the challenge, but we wanted our readers to know about the lengths that cosmetic companies will go to to get their business!
Since Dysport was approved slightly more than a year ago by the FDA, it’s taken only 10% of Botox’s thunder in terms of marketshare. However, Allergan, the makers of Botox, were spooked enough to push more of their non-cosmetic Botox uses to the public, such as a treatment for migraines and excessive sweating. In fact, those non-cosmetic uses make up more than half of Botox’s annual revenues!
This kind of medical marketing has upset some medical ethicists. I’d be interested in knowing what you think about this kind of promotion? Is this no different than the battle of the colas or does this signal a trend that might invade even our more disease-oriented medications, like perhaps Lipitor vs Zocor?
No comments:
Post a Comment